Biotech RadarJobs updated

COMPANY

Pathalys Pharma

HQ: Raleigh, NC source · pathalys.com ↗ · Southeast

Clinical Phase 3

Location: Raleigh, NC · source · Oct 15, 2026

Profile checked Oct 10, 2026

Keywords: Secondary Hyperparathyroidism End Stage Kidney Disease End-stage Kidney Disease PLS240

2Trials (company is sponsor)

Timeline

  1. Trial start Phase 3: Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-2 source ↗
  2. Trial start Phase 3: Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-1 source ↗

Clinical trials (lead sponsor) 2

RecordTitlePhaseStatusStartPrimary completion
NCT05836220Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-2Phase 3CompletedMay 15, 2023Aug 5, 2025 (actual)
NCT05832931Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-1Phase 3CompletedApr 28, 2023Jul 28, 2025 (actual)

Raises and investors new

Form D raises come from the company’s own SEC filing (last 2 years).

Feedback